Your browser doesn't support javascript.
Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.
Guevara, Rommel; Prado-Vivar, Belén; Márquez, Sully; Muñoz, Erika B; Carvajal, Mateo; Guadalupe, Juan José; Becerra-Wong, Mónica; Proaño, Stefanie; Bayas-Rea, Rosa; Coloma, Josefina; Grunauer, Michelle; Trueba, Gabriel; Rojas-Silva, Patricio; Barragán, Verónica; Cárdenas, Paúl.
  • Guevara R; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Prado-Vivar B; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Márquez S; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Muñoz EB; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Carvajal M; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Guadalupe JJ; Laboratorio de Biotecnología Vegetal, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Becerra-Wong M; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Proaño S; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Bayas-Rea R; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Coloma J; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California Berkeley, Berkeley, CA, United States.
  • Grunauer M; Escuela de Medicina, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Trueba G; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Rojas-Silva P; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Barragán V; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
  • Cárdenas P; Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
Front Cell Infect Microbiol ; 12: 951383, 2022.
Article in English | MEDLINE | ID: covidwho-2261478
ABSTRACT
SARS-CoV-2 reinfection is defined as a new infection with a different virus variant in an individual who has already recovered from a previous episode of COVID-19. The first case of reinfection in the world was described in August 2020, since then, reinfections have increased over time and their incidence has fluctuated with specific SARS-CoV-2 variant waves. Initially, reinfections were estimated to represent less than 1% of total COVID-19 infections. With the advent of the Omicron variant, reinfections became more frequent, representing up to 10% of cases (based on data from developed countries). The frequency of reinfections in Latin America has been scarcely reported. The current study shows that in Ecuador, the frequency of reinfections has increased 10-fold following the introduction of Omicron, after 22 months of surveillance in a single center of COVID-19 diagnostics. Suspected reinfections were identified retrospectively from a database of RT-qPCR-positive patients. Cases were confirmed by sequencing viral genomes from the first and second infections using the ONT MinION platform. Monthly surveillance showed that the main incidence peaks of reinfections were reached within four to five months, coinciding with the increase of COVID-19 cases in the country, suggesting that the emergence of reinfections is related to higher exposure to the virus during outbreaks. This study performed the longest monitoring of SARS-CoV-2 reinfections, showing an occurrence at regular intervals of 4-5 months and confirming a greater propensity of Omicron to cause reinfections.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study Topics: Variants Limits: Humans Country/Region as subject: South America / Ecuador Language: English Journal: Front Cell Infect Microbiol Year: 2022 Document Type: Article Affiliation country: Fcimb.2022.951383

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study Topics: Variants Limits: Humans Country/Region as subject: South America / Ecuador Language: English Journal: Front Cell Infect Microbiol Year: 2022 Document Type: Article Affiliation country: Fcimb.2022.951383